Profile
Larry Mattheakis worked as an Assistant Director at Affymax Research Institute from 1992 to 2000.
He then worked as a Senior Scientist at Cytokinetics, Inc. from 2002 to 2007.
From 2007 to 2011, he worked as an Associate Director at Exelixis, Inc. He also served as the Chief Scientific Officer & Executive VP at Annexon, Inc. from 2021 to 2023.
Additionally, he held the position of SVP-Discovery Biology & Translational Research at Protagonist Therapeutics, Inc. Dr. Mattheakis received his undergraduate degree from the University of California and his graduate and doctorate degrees from the University of Wisconsin.
Former positions of Larry Mattheakis
| Companies | Position | End |
|---|---|---|
| ANNEXON, INC. | Chief Tech/Sci/R&D Officer | 2023-01-05 |
| EXELIXIS, INC. | Corporate Officer/Principal | 2010-12-31 |
| CYTOKINETICS, INCORPORATED | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Corporate Officer/Principal | 1999-12-31 |
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Larry Mattheakis
| University of Wisconsin | Doctorate Degree |
| University of California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ANNEXON, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Commercial Services |
- Stock Market
- Insiders
- Larry Mattheakis
